Click here to get full coverage on Companies Like Amarin (NASDAQ:AMRN) Are In A Position To Invest In Growth - Sahm

Companies Like Amarin (NASDAQ:AMRN) Are In A Position To Invest In Growth  Sahm

Companies Like Amarin (NASDAQ:AMRN) Are In A Position To Invest In Growth - Sahm

Click here to get full coverage on How the Narrative Surrounding Amarin Is Evolving After New Data and Valuation Updates - Yahoo Finance

How the Narrative Surrounding Amarin Is Evolving After New Data and Valuation Updates  Yahoo Finance

How the Narrative Surrounding Amarin Is Evolving After New Data and Valuation Updates - Yahoo Finance

Click here to get full coverage on Amarin: Vascepa's Global Pivot From U.S. Squeeze To International Boom (NASDAQ:AMRN) - Seeking Alpha

Amarin: Vascepa's Global Pivot From U.S. Squeeze To International Boom (NASDAQ:AMRN)  Seeking Alpha

Amarin: Vascepa's Global Pivot From U.S. Squeeze To International Boom (NASDAQ:AMRN) - Seeking Alpha

Click here to get full coverage on Amarin (AMRN) Now Trades Above Golden Cross: Time to Buy? - Nasdaq

Amarin (AMRN) Now Trades Above Golden Cross: Time to Buy?  Nasdaq

Amarin (AMRN) Now Trades Above Golden Cross: Time to Buy? - Nasdaq

Click here to get full coverage on AMARIN Earnings Results: $AMRN Reports Quarterly Earnings - Quiver Quantitative

AMARIN Earnings Results: $AMRN Reports Quarterly Earnings  Quiver Quantitative

AMARIN Earnings Results: $AMRN Reports Quarterly Earnings - Quiver Quantitative

Click here to get full coverage on Amarin (NASDAQ: AMRN) shares REDUCE-IT aspirin analysis showing 36% fewer total CV events - Stock Titan

Amarin (NASDAQ: AMRN) shares REDUCE-IT aspirin analysis showing 36% fewer total CV events  Stock Titan

Amarin (NASDAQ: AMRN) shares REDUCE-IT aspirin analysis showing 36% fewer total CV events - Stock Titan

Click here to get full coverage on Amarin (AMRN) Surges 12.5%: Is This an Indication of Further Gains? - Yahoo Finance

Amarin (AMRN) Surges 12.5%: Is This an Indication of Further Gains?  Yahoo Finance

Amarin (AMRN) Surges 12.5%: Is This an Indication of Further Gains? - Yahoo Finance

Click here to get full coverage on Amarin Corporation plc (NASDAQ:AMRN) Stock Catapults 25% Though Its Price And Business Still Lag The Industry - simplywall.st

Amarin Corporation plc (NASDAQ:AMRN) Stock Catapults 25% Though Its Price And Business Still Lag The Industry  simplywall.st

Amarin Corporation plc (NASDAQ:AMRN) Stock Catapults 25% Though Its Price And Business Still Lag The Industry - simplywall.st

Click here to get full coverage on GNTA, BBIO, AMRN Jump After Hours: Key Biotech Catalysts Driving Stock Gains - Nasdaq

GNTA, BBIO, AMRN Jump After Hours: Key Biotech Catalysts Driving Stock Gains  Nasdaq

GNTA, BBIO, AMRN Jump After Hours: Key Biotech Catalysts Driving Stock Gains - Nasdaq

Click here to get full coverage on How the Narrative Around Amarin Is Shifting as Analyst Expectations Rise - Yahoo Finance

How the Narrative Around Amarin Is Shifting as Analyst Expectations Rise  Yahoo Finance

How the Narrative Around Amarin Is Shifting as Analyst Expectations Rise - Yahoo Finance

Click here to get full coverage on Amarin (AMRN) Could Find a Support Soon, Here's Why You Should Buy the Stock Now - Yahoo Finance

Amarin (AMRN) Could Find a Support Soon, Here's Why You Should Buy the Stock Now  Yahoo Finance

Amarin (AMRN) Could Find a Support Soon, Here's Why You Should Buy the Stock Now - Yahoo Finance

Click here to get full coverage on Earnings To Watch: Amarin Corp PLC (AMRN) Reports Q3 2025 Results - Yahoo Finance

Earnings To Watch: Amarin Corp PLC (AMRN) Reports Q3 2025 Results  Yahoo Finance

Earnings To Watch: Amarin Corp PLC (AMRN) Reports Q3 2025 Results - Yahoo Finance

Click here to get full coverage on What To Expect From Amarin Corp PLC (AMRN) Q2 2025 Earnings - Yahoo Finance

What To Expect From Amarin Corp PLC (AMRN) Q2 2025 Earnings  Yahoo Finance

What To Expect From Amarin Corp PLC (AMRN) Q2 2025 Earnings - Yahoo Finance

Click here to get full coverage on Amarin (AMRN): Deep Discount Reinforces Market Caution Despite Projected Earnings Growth - Yahoo Finance

Amarin (AMRN): Deep Discount Reinforces Market Caution Despite Projected Earnings Growth  Yahoo Finance

Amarin (AMRN): Deep Discount Reinforces Market Caution Despite Projected Earnings Growth - Yahoo Finance

Click here to get full coverage on Amarin Corp PLC (AMRN) Q1 2025 Earnings Call Highlights: Strategic Global Expansion Amidst ... - Yahoo Finance

Amarin Corp PLC (AMRN) Q1 2025 Earnings Call Highlights: Strategic Global Expansion Amidst ...  Yahoo Finance

Amarin Corp PLC (AMRN) Q1 2025 Earnings Call Highlights: Strategic Global Expansion Amidst ... - Yahoo Finance

Click here to get full coverage on Amarin (AMRN) Upgraded to Strong Buy: What Does It Mean for the Stock? - Yahoo Finance

Amarin (AMRN) Upgraded to Strong Buy: What Does It Mean for the Stock?  Yahoo Finance

Amarin (AMRN) Upgraded to Strong Buy: What Does It Mean for the Stock? - Yahoo Finance

Click here to get full coverage on Amarin Corp PLC (AMRN) Q3 2025 Earnings Call Highlights: Revenue Growth and Strategic ... - Yahoo Finance

Amarin Corp PLC (AMRN) Q3 2025 Earnings Call Highlights: Revenue Growth and Strategic ...  Yahoo Finance

Amarin Corp PLC (AMRN) Q3 2025 Earnings Call Highlights: Revenue Growth and Strategic ... - Yahoo Finance

Click here to get full coverage on Amarin's Q2 Earnings & Revenues Trump Estimates, Stock Rises - Yahoo Finance

Amarin's Q2 Earnings & Revenues Trump Estimates, Stock Rises  Yahoo Finance

Amarin's Q2 Earnings & Revenues Trump Estimates, Stock Rises - Yahoo Finance

Click here to get full coverage on Amarin Gears Up to Report Q2 Earnings: Here's What to Expect - Yahoo Finance

Amarin Gears Up to Report Q2 Earnings: Here's What to Expect  Yahoo Finance

Amarin Gears Up to Report Q2 Earnings: Here's What to Expect - Yahoo Finance

Click here to get full coverage on Is Amarin (AMRN) Stock Outpacing Its Medical Peers This Year? - Nasdaq

Is Amarin (AMRN) Stock Outpacing Its Medical Peers This Year?  Nasdaq

Is Amarin (AMRN) Stock Outpacing Its Medical Peers This Year? - Nasdaq

Click here to get full coverage on Amarin sells heart pill Vascepa's rights in Europe to Recordati amid restructuring bid - Fierce Pharma

Amarin sells heart pill Vascepa's rights in Europe to Recordati amid restructuring bid  Fierce Pharma

Amarin sells heart pill Vascepa's rights in Europe to Recordati amid restructuring bid - Fierce Pharma

Click here to get full coverage on Amarin Is A Sell Despite The Large Cash Balance (NASDAQ:AMRN) - Seeking Alpha

Amarin Is A Sell Despite The Large Cash Balance (NASDAQ:AMRN)  Seeking Alpha

Amarin Is A Sell Despite The Large Cash Balance (NASDAQ:AMRN) - Seeking Alpha

Click here to get full coverage on Q3 2025 Results: Amarin to Release Pre‑Market; Conference Call Oct 29 — Webcast & Replay Available - Stock Titan

Q3 2025 Results: Amarin to Release Pre‑Market; Conference Call Oct 29 — Webcast & Replay Available  Stock Titan

Q3 2025 Results: Amarin to Release Pre‑Market; Conference Call Oct 29 — Webcast & Replay Available - Stock Titan

Click here to get full coverage on Amarin stock rises after ESC Congress data on VASCEPA mechanism - Investing.com

Amarin stock rises after ESC Congress data on VASCEPA mechanism  Investing.com

Amarin stock rises after ESC Congress data on VASCEPA mechanism - Investing.com

Click here to get full coverage on Amarin (AMRN) Unprofitable as Losses Worsen, Profit Growth Forecasts Test Bullish Turnaround Hopes - simplywall.st

Amarin (AMRN) Unprofitable as Losses Worsen, Profit Growth Forecasts Test Bullish Turnaround Hopes  simplywall.st

Amarin (AMRN) Unprofitable as Losses Worsen, Profit Growth Forecasts Test Bullish Turnaround Hopes - simplywall.st

Click here to get full coverage on Amarin stock rises as Goldman Sachs raises price target on EU deal - Investing.com

Amarin stock rises as Goldman Sachs raises price target on EU deal  Investing.com

Amarin stock rises as Goldman Sachs raises price target on EU deal - Investing.com

Click here to get full coverage on Amarin stock jumps after $25 million licensing deal with Recordati - Investing.com

Amarin stock jumps after $25 million licensing deal with Recordati  Investing.com

Amarin stock jumps after $25 million licensing deal with Recordati - Investing.com

Click here to get full coverage on Amarin Takes Critical Step to Avoid Nasdaq Delisting with 1-for-20 Share Consolidation - Stock Titan

Amarin Takes Critical Step to Avoid Nasdaq Delisting with 1-for-20 Share Consolidation  Stock Titan

Amarin Takes Critical Step to Avoid Nasdaq Delisting with 1-for-20 Share Consolidation - Stock Titan

Click here to get full coverage on U.S. Supreme Court Invites Solicitor General to Submit Briefing on "Skinny Labels" - Jones Day

U.S. Supreme Court Invites Solicitor General to Submit Briefing on "Skinny Labels"  Jones Day

U.S. Supreme Court Invites Solicitor General to Submit Briefing on "Skinny Labels" - Jones Day

Click here to get full coverage on Amarin (NASDAQ:AMRN) Downgraded by Wall Street Zen to Buy - MarketBeat

Amarin (NASDAQ:AMRN) Downgraded by Wall Street Zen to Buy  MarketBeat

Amarin (NASDAQ:AMRN) Downgraded by Wall Street Zen to Buy - MarketBeat

Click here to get full coverage on (AMRN) Risk Channels and Responsive Allocation - news.stocktradersdaily.com

(AMRN) Risk Channels and Responsive Allocation  news.stocktradersdaily.com

(AMRN) Risk Channels and Responsive Allocation - news.stocktradersdaily.com

Click here to get full coverage on Amarin Soars 27% on Vazkepa Licensing Deal With Recordati in the EU - Yahoo Finance

Amarin Soars 27% on Vazkepa Licensing Deal With Recordati in the EU  Yahoo Finance

Amarin Soars 27% on Vazkepa Licensing Deal With Recordati in the EU - Yahoo Finance

Click here to get full coverage on Amarin Corp PLC (AMRN) Q4 2024 Earnings Call Highlights: Navigating Challenges and Expanding ... - Yahoo Finance

Amarin Corp PLC (AMRN) Q4 2024 Earnings Call Highlights: Navigating Challenges and Expanding ...  Yahoo Finance

Amarin Corp PLC (AMRN) Q4 2024 Earnings Call Highlights: Navigating Challenges and Expanding ... - Yahoo Finance

Click here to get full coverage on Leerink Partners raises Amarin stock price target to $12 on strong Q3 - Investing.com

Leerink Partners raises Amarin stock price target to $12 on strong Q3  Investing.com

Leerink Partners raises Amarin stock price target to $12 on strong Q3 - Investing.com

Click here to get full coverage on Investor group calls for strategy shift as Amarin shares continue to flounder post-Sarissa Capital takeover - Fierce Pharma

Investor group calls for strategy shift as Amarin shares continue to flounder post-Sarissa Capital takeover  Fierce Pharma

Investor group calls for strategy shift as Amarin shares continue to flounder post-Sarissa Capital takeover - Fierce Pharma

Click here to get full coverage on Amarin Corporation Q2 2025 Financial Results - TradingView

Amarin Corporation Q2 2025 Financial Results  TradingView

Amarin Corporation Q2 2025 Financial Results - TradingView

Click here to get full coverage on 44% Cardiovascular Risk Reduction: Amarin's VASCEPA Proves Powerful in Multiple High-Risk Patient Groups at ESC - Stock Titan

44% Cardiovascular Risk Reduction: Amarin's VASCEPA Proves Powerful in Multiple High-Risk Patient Groups at ESC  Stock Titan

44% Cardiovascular Risk Reduction: Amarin's VASCEPA Proves Powerful in Multiple High-Risk Patient Groups at ESC - Stock Titan

Click here to get full coverage on Do Options Traders Know Something About Amarin Stock We Don't? - Nasdaq

Do Options Traders Know Something About Amarin Stock We Don't?  Nasdaq

Do Options Traders Know Something About Amarin Stock We Don't? - Nasdaq

Click here to get full coverage on We Think Amarin (NASDAQ:AMRN) Can Afford To Drive Business Growth - simplywall.st

We Think Amarin (NASDAQ:AMRN) Can Afford To Drive Business Growth  simplywall.st

We Think Amarin (NASDAQ:AMRN) Can Afford To Drive Business Growth - simplywall.st

Click here to get full coverage on Amarin announces ADS ratio change to meet Nasdaq requirements - Investing.com

Amarin announces ADS ratio change to meet Nasdaq requirements  Investing.com

Amarin announces ADS ratio change to meet Nasdaq requirements - Investing.com

Click here to get full coverage on (AMRN) Movement as an Input in Quant Signal Sets - news.stocktradersdaily.com

(AMRN) Movement as an Input in Quant Signal Sets  news.stocktradersdaily.com

(AMRN) Movement as an Input in Quant Signal Sets - news.stocktradersdaily.com

Click here to get full coverage on Amarin Corporation and HLS Therapeutics to Present Scientific Data on Icosapent Ethyl at Canadian Cardiovascular Congress 2025 - Quiver Quantitative

Amarin Corporation and HLS Therapeutics to Present Scientific Data on Icosapent Ethyl at Canadian Cardiovascular Congress 2025  Quiver Quantitative

Amarin Corporation and HLS Therapeutics to Present Scientific Data on Icosapent Ethyl at Canadian Cardiovascular Congress 2025 - Quiver Quantitative

Click here to get full coverage on Amarin Reports Third Quarter 2025 Financial Results - TradingView

Amarin Reports Third Quarter 2025 Financial Results  TradingView

Amarin Reports Third Quarter 2025 Financial Results - TradingView

Click here to get full coverage on Amarin Corporation’s Earnings Call Highlights Growth and Challenges - TipRanks

Amarin Corporation’s Earnings Call Highlights Growth and Challenges  TipRanks

Amarin Corporation’s Earnings Call Highlights Growth and Challenges - TipRanks

Click here to get full coverage on Hikma and Amici Curiae Ask Supreme Court to Revisit Induced Infringement by Generic “Skinny Labels” - Crowell & Moring LLP

Hikma and Amici Curiae Ask Supreme Court to Revisit Induced Infringement by Generic “Skinny Labels”  Crowell & Moring LLP

Hikma and Amici Curiae Ask Supreme Court to Revisit Induced Infringement by Generic “Skinny Labels” - Crowell & Moring LLP

Click here to get full coverage on Earnings call transcript: Amarin Q2 2025 sees revenue beat, stock stable - Investing.com

Earnings call transcript: Amarin Q2 2025 sees revenue beat, stock stable  Investing.com

Earnings call transcript: Amarin Q2 2025 sees revenue beat, stock stable - Investing.com

Click here to get full coverage on Amarin Corp PLC Q3 2025 Earnings: EPS of -$0.02 Beats Estimates, Revenue Surges to $49.7 Million - GuruFocus

Amarin Corp PLC Q3 2025 Earnings: EPS of -$0.02 Beats Estimates, Revenue Surges to $49.7 Million  GuruFocus

Amarin Corp PLC Q3 2025 Earnings: EPS of -$0.02 Beats Estimates, Revenue Surges to $49.7 Million - GuruFocus

Click here to get full coverage on Amarin Corporation Highlights New Analysis Supporting Cardiovascular Benefits of Icosapent Ethyl in REDUCE-IT Trial - Quiver Quantitative

Amarin Corporation Highlights New Analysis Supporting Cardiovascular Benefits of Icosapent Ethyl in REDUCE-IT Trial  Quiver Quantitative

Amarin Corporation Highlights New Analysis Supporting Cardiovascular Benefits of Icosapent Ethyl in REDUCE-IT Trial - Quiver Quantitative

Click here to get full coverage on Recordati acquires rights to cardio med from Amarin - The Pharma Letter

Recordati acquires rights to cardio med from Amarin  The Pharma Letter

Recordati acquires rights to cardio med from Amarin - The Pharma Letter

Click here to get full coverage on Amarin Appoints David Keenan as COO - TipRanks

Amarin Appoints David Keenan as COO  TipRanks

Amarin Appoints David Keenan as COO - TipRanks

Click here to get full coverage on Amarin Corporation Plc's (NASDAQ:AMRN) Shares Bounce 25% But Its Business Still Trails The Industry - 富途牛牛

Amarin Corporation Plc's (NASDAQ:AMRN) Shares Bounce 25% But Its Business Still Trails The Industry  富途牛牛

Amarin Corporation Plc's (NASDAQ:AMRN) Shares Bounce 25% But Its Business Still Trails The Industry - 富途牛牛

Click here to get full coverage on Amarin Corporation Reports Q3 2025 Financial Results - TipRanks

Amarin Corporation Reports Q3 2025 Financial Results  TipRanks

Amarin Corporation Reports Q3 2025 Financial Results - TipRanks

Click here to get full coverage on Amarin Announces 1-for-20 Reverse Stock Split - TipRanks

Amarin Announces 1-for-20 Reverse Stock Split  TipRanks

Amarin Announces 1-for-20 Reverse Stock Split - TipRanks

Click here to get full coverage on Amarin (AMRN) to Showcase Cardiovascular Research at Canadian Co - GuruFocus

Amarin (AMRN) to Showcase Cardiovascular Research at Canadian Co  GuruFocus

Amarin (AMRN) to Showcase Cardiovascular Research at Canadian Co - GuruFocus

Click here to get full coverage on Amarin Enters Licensing Agreement with Recordati - TipRanks

Amarin Enters Licensing Agreement with Recordati  TipRanks

Amarin Enters Licensing Agreement with Recordati - TipRanks

Click here to get full coverage on Amarin to present new data on VASCEPA at AHA Scientific Sessions - Investing.com

Amarin to present new data on VASCEPA at AHA Scientific Sessions  Investing.com

Amarin to present new data on VASCEPA at AHA Scientific Sessions - Investing.com

Click here to get full coverage on Amarin's Q3 Earnings Lag Estimates, Revenues Beat, Stock Down - Yahoo Finance

Amarin's Q3 Earnings Lag Estimates, Revenues Beat, Stock Down  Yahoo Finance

Amarin's Q3 Earnings Lag Estimates, Revenues Beat, Stock Down - Yahoo Finance

Click here to get full coverage on Amarin Announces ADS Ratio Change to Maintain Nasdaq Listing - TipRanks

Amarin Announces ADS Ratio Change to Maintain Nasdaq Listing  TipRanks

Amarin Announces ADS Ratio Change to Maintain Nasdaq Listing - TipRanks

Click here to get full coverage on Amarin Appoints JEC Capital Partners’ Michael Torok to Board of Directors - citybiz

Amarin Appoints JEC Capital Partners’ Michael Torok to Board of Directors  citybiz

Amarin Appoints JEC Capital Partners’ Michael Torok to Board of Directors - citybiz

Click here to get full coverage on Amarin Corporation plc to Host Conference Call for First Quarter 2025 Financial Results - Quiver Quantitative

Amarin Corporation plc to Host Conference Call for First Quarter 2025 Financial Results  Quiver Quantitative

Amarin Corporation plc to Host Conference Call for First Quarter 2025 Financial Results - Quiver Quantitative

Click here to get full coverage on Amarin to Report Second Quarter 2025 Financial Results and Host Conference Call on July 30, 2025 - The Manila Times

Amarin to Report Second Quarter 2025 Financial Results and Host Conference Call on July 30, 2025  The Manila Times

Amarin to Report Second Quarter 2025 Financial Results and Host Conference Call on July 30, 2025 - The Manila Times

Click here to get full coverage on Amarin Reports Third Quarter 2025 Financial Results - The Manila Times

Amarin Reports Third Quarter 2025 Financial Results  The Manila Times

Amarin Reports Third Quarter 2025 Financial Results - The Manila Times

Click here to get full coverage on Amarin to Report Third Quarter 2025 Financial Results and Host Conference Call on October 29, 2025 - The Manila Times

Amarin to Report Third Quarter 2025 Financial Results and Host Conference Call on October 29, 2025  The Manila Times

Amarin to Report Third Quarter 2025 Financial Results and Host Conference Call on October 29, 2025 - The Manila Times

Click here to get full coverage on VKTX Stock Down on Wider-Than-Expected Loss in Q2, Nil Sales - The Globe and Mail

VKTX Stock Down on Wider-Than-Expected Loss in Q2, Nil Sales  The Globe and Mail

VKTX Stock Down on Wider-Than-Expected Loss in Q2, Nil Sales - The Globe and Mail

Click here to get full coverage on After Plunging -19.13% in 4 Weeks, Here's Why the Trend Might Reverse for Amarin (AMRN) - Yahoo Finance

After Plunging -19.13% in 4 Weeks, Here's Why the Trend Might Reverse for Amarin (AMRN)  Yahoo Finance

After Plunging -19.13% in 4 Weeks, Here's Why the Trend Might Reverse for Amarin (AMRN) - Yahoo Finance

Click here to get full coverage on Amarin granted extension to meet Nasdaq listing standards - Investing.com

Amarin granted extension to meet Nasdaq listing standards  Investing.com

Amarin granted extension to meet Nasdaq listing standards - Investing.com

Click here to get full coverage on Amarin: Headwinds Persist Both In The United States And Europe (NASDAQ:AMRN) - Seeking Alpha

Amarin: Headwinds Persist Both In The United States And Europe (NASDAQ:AMRN)  Seeking Alpha

AMRN

Price Chart

Key Statistics

Technicals

About AMRN

Latest News

Companies Like Amarin (NASDAQ:AMRN) Are In A Position To Invest In Growth - Sahm

How the Narrative Surrounding Amarin Is Evolving After New Data and Valuation Updates - Yahoo Finance

Amarin: Vascepa's Global Pivot From U.S. Squeeze To International Boom (NASDAQ:AMRN) - Seeking Alpha

Advanced Charts

Top Gainers

Top Losers